Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat in cystic fibrosis (2.5 µg vs 5 µg vs placebo)
2008-001156-43Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tiotropium in cystic fibrosis (CF) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Bronchodilator efficacy (lung function) and Safety of tiotropium bromide. Started Jun 2008; status: completed.
02
Drugs
tiotropium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2008-001156-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001156-43.